Summer Street Downgrades BioMimetic Therapeutics (BMTI) to Neutral
Tweet Send to a FriendGet Alerts BMTI Hot Sheet
Price: $9.49 --0%
Rating Summary:
1 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
1 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Trade BMTI Now!
Summer Street downgraded BioMimetic Therapeutics (NASDAQ: BMTI) from Buy to Neutral.
For an analyst ratings summary and ratings history on BioMimetic Therapeutics click here. For more ratings news on BioMimetic Therapeutics click here.
Shares of BioMimetic Therapeutics closed at $8.85 yesterday, with a 52 week range of $2.01-$8.98.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on BioMimetic Therapeutics click here. For more ratings news on BioMimetic Therapeutics click here.
Shares of BioMimetic Therapeutics closed at $8.85 yesterday, with a 52 week range of $2.01-$8.98.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Macquarie Downgrades Barrick Gold (ABX) to Underperform
- SunTrust Robinson Humphrey Downgrades Zimmer Holdings (ZMH) to Reduce
- Goldman Sachs Downgrades Deere (DE) to Sell, Sees 5% Downside
Create E-mail Alert Related Categories
Downgrades
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
